By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioXell S.p.A. 

Via Olgettina 58

Milano    20132  Italy
Phone: 39-02-2104951 Fax: 39-02-21049555



Merck & Co.  Sepsis

Company News
Cosmo Pharmaceuticals S.p.A. Announces Preliminary End Result Of Its Tender Offer For BioXell S.p.A. 3/1/2010 11:53:19 AM
Cosmo Pharmaceuticals S.p.A. Publishes Public Tender Offer For BioXell S.p.A. 12/8/2009 11:29:23 AM
Biotech Cosmo Pharmaceuticals S.p.A. Aims to Buy Rival BioXell S.p.A. for $41 Million 11/18/2009 8:29:06 AM
Shares Tumble as BioXell S.p.A. Lead Drug Fails in Trial 4/9/2009 11:05:43 AM
BioXell S.p.A. Completes Recruitment For Phase IIb Trial Of Elocalcitol In Benign Prostatic Hyperplasia 12/15/2006 10:31:20 AM
BioXell S.p.A.: Invitation To R&D Day 9/27/2006 5:07:40 PM
BioXell S.p.A. Announces Phase II Results For Elocalcitol In Overactive Bladder 5/11/2006 1:45:27 PM
BioXell S.p.A.l Raises Additional €10.5 Million In Private Financing Led By TVM Capital 3/15/2006 1:38:52 PM
BioXell S.p.A. And Lay Line Genomics S.p.A. Announce License Agreement For Anti-TrkA Antibody Against Pain 2/13/2006 2:12:20 PM
BioXell S.p.A. Promotes Meenu Chhabra To Chief Business Officer 1/24/2006 6:52:30 PM